Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10014264 | 0.82 | PKM (0.38) | PKMNPSR1LMNATP53MAPT | |
| SCHEMBL22474104 | 0.81 | ESR2 (0.42) | PKMNPSR1LMNATP53MAPT | |
| SCHEMBL12918619 | 0.81 | MAPT (0.38) | PKMNPSR1LMNATP53MAPT | |
| SCHEMBL12754471 | 0.81 | MAPT (0.38) | PKMNPSR1LMNATP53MAPT | |
| SCHEMBL27322339 | 0.80 | HSD11B1 (0.32) | — | |
| SCHEMBL10311704 | 0.78 | RAB9A (0.35) | PKMNPSR1LMNATP53MAPT | |
| SCHEMBL12361197 | 0.76 | RAB9A (0.40) | PKMNPSR1LMNAMAPTATM | |
| SCHEMBL13785220 | 0.76 | — | — | |
| SCHEMBL12829104 | 0.73 | TSHR (0.39) | PKMNPSR1LMNATP53MAPT | |
| SCHEMBL12754470 | 0.73 | TSHR (0.39) | PKMNPSR1LMNATP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544365-B2 | Nematic liquid crystal composition | DIC CORPORATION (JP) | 2020-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544365-B2 | Nematic liquid crystal composition | DOCK5, CDKL5, NCS1 | PKM 4334/4885NPSR1 3815/4885LMNA 1467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.